Correction: Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study

被引：0
|
作者：
Carlo Visco
Alice Di Rocco
Andrea Evangelista
Francesca Maria Quaglia
Maria Chiara Tisi
Lucia Morello
Vittorio Ruggero Zilioli
Chiara Rusconi
Stefan Hohaus
Roberta Sciarra
Alessandro Re
Cristina Tecchio
Annalisa Chiappella
Ana Marin-Niebla
Rory McCulloch
Guido Gini
Tommasina Perrone
Luca Nassi
Elsa Pennese
Piero Maria Stefani
Maria Christina Cox
Valentina Bozzoli
Alberto Fabbri
Valentina Polli
Simone Ferrero
Maria Isabel Alvarez De Celis
Antonello Sica
Luca Petrucci
Luca Arcaini
Simon Rule
Mauro Krampera
Umberto Vitolo
Monica Balzarotti
机构：
[1] University of Verona,Department of Medicine, Section of Hematology
[2] Sapienza University,Department of Translational and Precision Medicine
[3] Azienda Ospedaliera Universitaria Città della Salute e della Scienza and CPO Piemonte,Unit of Clinical Epidemiology
[4] University of Verona,Department of Medicine, Section of Hematology
[5] San Bortolo Hospital,Cell Therapy and Hematology
[6] Humanitas Cancer Center,Humanitas Clinical and Research Center—IRCCS
[7] ASST Grande Ospedale Metropolitano Niguarda,Hematology
[8] IRCSS Istituto Nazionale Tumori,Hematology and Bone Marrow Transplantation
[9] Università Cattolica del Sacro Cuore,Hematology, Fondazione Policlinico Universitario A. Gemelli
[10] Fondazione IRCCS Policlinico San Matteo,Haematology
[11] Spedali Civili,Hematology
[12] “Città della Salute e della Scienza di Torino” University Hospital,Hematology
[13] Vall d’Hebron Institut of Oncology,Hematology
[14] University of Plymouth and Derriford Hospital,Haematology
[15] Department of Clinical and Molecular Sciences,Hematology
[16] Marche Polytechnic University,Hematology
[17] University of Bari,Hematology
[18] Azienda Ospedaliero-Universitaria Maggiore della Carità,Hematology
[19] UOSD “Centro Diagnosi e Terapia dei Linfomi”,Hematology
[20] PO Santo Spirito,Hematology
[21] General Hospital Ca’ Foncello,Hematology
[22] AOU Sant’Andrea,Hematology
[23] P.O. V. Fazzi,Hematology
[24] Azienda Ospedaliera Universitaria Senese & University of Siena,Hematology, Department of Molecular Biotechnologies and Health Sciences
[25] Ospedale degli Infermi,Hematology
[26] University of Torino/“Città della Salute e della Scienza di Torino” University Hospital,Hematology
[27] AUSLL/IRCCS Santa Maria Nuova Hospital,undefined
[28] Policlinico di Napoli,undefined
[29] Candiolo Cancer Institute,undefined
[30] FPO-IRCCS,undefined
来源：
Leukemia | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A Correction to this paper has been published: https://doi.org/10.1038/s41375-020-01119-8
引用
收藏
页码：932 / 932
相关论文
共 50 条
  • [41] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Yamasaki, Satoshi
    Chihara, Dai
    Kim, Sung-Won
    Izutsu, Koji
    Iwato, Kouji
    Fukuda, Takahiro
    Uchida, Naoyuki
    Amano, Itsuto
    Nakazawa, Hideyuki
    Kuroda, Junya
    Hashimoto, Hisako
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1445 - 1452
  • [42] Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
    Bock, Allison M.
    Gile, Jennifer J.
    Larson, Melissa C.
    Poonsombudlert, Kittika
    Tawfiq, Reema K.
    Maliske, Seth
    Maurer, Matthew J.
    Kabat, Brian F.
    Paludo, Jonas
    Inwards, David J.
    Ayyappan, Sabarish
    Link, Brian K.
    Ansell, Stephen M.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Cerhan, James R.
    Farooq, Umar
    Wang, Yucai
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [43] Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: First Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial
    Jerkeman, Mats
    Hutchings, Martin
    Raty, Riikka
    Wader, Karin Fahl
    Laurell, Anna
    Kuitunen, Hanne
    Toldbod, Helle
    Pedersen, Lone Bredo
    Eskelund, Christian Winther
    Gronbaek, Kirsten
    Niemann, Carsten Utoft
    Geisler, Christian H.
    Kolstad, Arne
    BLOOD, 2016, 128 (22)
  • [44] Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective
    Desai, Madhav
    Newberry, Kate
    Ou, Zhishuo
    Wang, Michael
    Zhang, Liang
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (03) : 91 - 101
  • [45] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Satoshi Yamasaki
    Dai Chihara
    Sung-Won Kim
    Koji Izutsu
    Kouji Iwato
    Takahiro Fukuda
    Naoyuki Uchida
    Itsuto Amano
    Hideyuki Nakazawa
    Junya Kuroda
    Hisako Hashimoto
    Tatsuo Ichinohe
    Yoshinobu Kanda
    Yoshiko Atsuta
    Junji Suzumiya
    Ritsuro Suzuki
    Annals of Hematology, 2018, 97 : 1445 - 1452
  • [46] Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma
    Maddocks, Kami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S187 - S188
  • [47] Mantle Cell Lymphoma: Updates in the Management of Relapsed/Refractory Disease
    Shadman, Mazyar
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11.5): : 1331 - 1333
  • [48] Ibrutinib in refractory mantle cell lymphoma or relapsed data update
    Paillassa, Jerome
    HEMATOLOGIE, 2015, 21 (05): : 257 - 259
  • [49] Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma Profile Report
    Hoy, Sheridan M.
    McKeage, Kate
    BIODRUGS, 2011, 25 (03) : 193 - 195
  • [50] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
    Mian, Agrima
    Hill, Brian T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
12345